Accelerating Evidence to Action in Pharma with Practical AI Adoption - with Nabil Khan of Pfizer

Welcome, everyone, to the Emerge AI business podcast.

It goes beyond the title with direct discussion of it's, information, think, including: Today's guest is Nabil Khan, Medical Director for Internal Medicine Antivirals at Pfizer.

1. 01Just a quick note for our audience that the views expressed by Nabil Khan on today's program do not reflect that of Pfizer or its leadership
2. 02In this episode, we cover evidence to good decision workflows
3. 03For example, if one of the problems you're running into is, let's say you're running a clinical trial and you are unable to locate relevant clinical trial sites